SOURCE: UpLift Nutrition, Inc.

UpLift Nutrition, Inc.

November 10, 2009 09:00 ET

UpLift Nutrition to Implement Nationwide Investor Relations Program

ROY, UT--(Marketwire - November 10, 2009) - UpLift Nutrition, Inc. ( (OTCBB: UPNT) announced today it has retained Mirador Consulting, Inc., a full service corporate consulting firm, to establish a nationwide investor relations campaign.

Under the agreement, Mirador Consulting shall implement an investor relations program including stockbroker relations, media relations, shareholder and investor communications.

"We look forward to working with Mirador to enhance our visibility in the investment community and the financial media as we seek to become a premier developer and distributor of research-driven nutritional products," said Gary Lewis, the Company's President.

Mirador Consulting ( is a full-service corporate consulting firm. Mirador specializes in micro-cap and middle market NASDAQ-listed companies, providing nationwide representation to members of the investment community.

About UpLift Nutrition (

UpLift Nutrition's mission is to utilize the latest and best science available to produce nutritional products. We will constantly strive to offer products that benefit all, while remaining mindful of protecting and preserving Mother Nature's finite resources.

To view all of UpLift's filings visit, click on "Search for Company Filings" under the Filings & Forms heading, click on "Companies and Other Filers," and enter UpLift Nutrition.

This press release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update these statements to reflect actual results, changes in assumptions or other factors. Without limitation, these risks and uncertainties include the Company's dependence on its ability to market this, or any other product the Company may attempt now or in the future. Readers should review and consider the various disclosures made by the Company in its reports to its shareholders and the Securities and Exchange Commission.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Contact Information

  • For Further Information:
    Gary C. Lewis
    Tel: (801) 721-4410
    Fax: (801) 732-8978

    Frank Benedetto
    Mirador Consulting, Inc.
    Phone: 561-989-3600 or 877-647-2367